We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
Novartis is reportedly planning to cease approximately 20% of its drug research projects, following a strategic review, in order to focus on other priority therapeutic areas.
Zika virus (ZIKV) spread rapidly worldwide since its outbreak in May 2015 and was listed as a “public health emergency of international concern” by WHO.